Therapeutic Antibodies for the Treatment of Pancreatic Cancer

Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Chames, Patrick, Kerfelec, Brigitte, Baty, Daniel
Format: Artigo
Language:Inglês
Published: TheScientificWorldJOURNAL 2010
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2925140/
https://ncbi.nlm.nih.gov/pubmed/20563534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2010.103
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items